GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 59 filers reported holding GAMIDA CELL LTD in Q2 2022. The put-call ratio across all filers is 3.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,049 | -46.6% | 53,446 | 0.0% | 0.00% | – |
| Q2 2023 | $103,150 | +249.7% | 53,446 | +46.8% | 0.00% | – |
| Q1 2023 | $29,497 | +64023.9% | 36,417 | 0.0% | 0.00% | – |
| Q4 2022 | $46 | -99.9% | 36,417 | 0.0% | 0.00% | – |
| Q3 2022 | $57,000 | -10.9% | 36,417 | 0.0% | 0.00% | – |
| Q2 2022 | $64,000 | -57.6% | 36,417 | 0.0% | 0.00% | – |
| Q1 2022 | $151,000 | +371.9% | 36,417 | +186.7% | 0.00% | – |
| Q4 2021 | $32,000 | -34.7% | 12,700 | 0.0% | 0.00% | – |
| Q3 2021 | $49,000 | -75.5% | 12,700 | -59.4% | 0.00% | – |
| Q2 2021 | $200,000 | -20.6% | 31,257 | 0.0% | 0.00% | – |
| Q1 2021 | $252,000 | +65.8% | 31,257 | +72.0% | 0.00% | – |
| Q4 2020 | $152,000 | +102.7% | 18,175 | 0.0% | 0.00% | – |
| Q3 2020 | $75,000 | -9.6% | 18,175 | 0.0% | 0.00% | – |
| Q2 2020 | $83,000 | – | 18,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187 | $107,000,000 | 1.12% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $307,000 | 0.28% |
| Rock Springs Capital Management LP | 2,175,000 | $3,850,000 | 0.11% |
| Platform Technology Partners | 57,625 | $102,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,197,875 | $2,120,000 | 0.05% |
| Guild Investment Management, Inc. | 18,000 | $28,000 | 0.04% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $760,000 | 0.01% |
| 1492 Capital Management LLC | 10,000 | $18,000 | 0.01% |
| ARK Investment Management | 714,534 | $1,558,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,868,896 | $3,308,000 | 0.01% |